Pfizer in class action settlement talks

Pfizer will hold initial settlement discussions with Australian class action lawyers over claims a Parkinson’s drug triggered patients’ compulsive gambling and hypersexuality.

About 200 people have joined the lawsuit against the drug company, which manufactures cabergoline (Cabaser and Dostinex), as well as Aspen Pharmacare and Eli Lily, the makers of pergolide (Permax).

Documents filed in the Federal Court last year by Melbourne law firm Arnold Thomas & Becker allege the companies failed to adequately warn consumers that compulsive